Leishmania donovani is a human blood parasite that belongs to the genus Leishmania. We would like to present a case of late Leishmania donovani endophthalmitis in one eye of a patient that underwent simultaneous bilateral grade 3 cataract surgery.
Both Verisyse and Veriflex pIOLs are effective in correcting myopia. The Veriflex lens demonstrated better refractive outcome; however, subclinical inflammation observed in the Veriflex group and potential influence of inflammation on ECC loss require further investigation.
Background: Axenfeld-Rieger Syndrome is a rare genetic disease affecting multiple organ systems. In the eye, it can be manifested with varying degrees of anterior segment dysgenesis and it carries a high risk of glaucoma.
Methods:We describe a case of 23 year old male patient with Axenfeld-Rieger syndrome who had bilateral cataract surgeries with IOL/iris diaphragm implantation prior to the referral. After those procedures he developed high and uncontrolled intraocular pressure (IOP) on both eyes. Since the patient was from the rural part of the country, we decided to perform same day bilateral glaucoma surgery with Ex-Press glaucoma shunt implantation. Both surgeries were done by the same surgeon.Results: At first postoperative day, both eyes had slight hypotony, so the additional viscoelastic has been instilled in the anterior chambers to maintain the pressure. There was no retinal, nor choroidal detachment. Throughout the follow up period, the IOP was stabile without any additional medications, visual acuity improved significantly and there were no other postoperative complications.
Conclusion:Ex-Press glaucoma shunt can be very useful in treating secondary glaucoma due to rarely seen genetic diseases which can affect eyes, and it can be safely implanted as a same day bilateral procedure.
Introduction. Keratoconus is the most common primary ectasia and has a signifi cant effect on visual acuity and the quality of life. The prevalence of keratoconus in the general population of Bosnia & Herzegovina, and Croatia remains unknown. This study was designed to show the incidence of keratoconus in candidates for Excimer laser refractive surgical procedures in our eye clinics. Methods. We analyzed preoperative examination data from 2,714 patients, collected over a two year period, who were candidates for Excimer refractive surgical procedures. Patients were sorted into groups according to their gender, age, degree of keratoconus (Amsler-Krumeich classifi cation) and involvement of one or both eyes. Results. Keratoconus was detected in 231 patients (335 eyes); 133 of the patients were male and 99 were female. Unilateral keratoconus was found in 127, and bilateral in 104 patients. Four age groups were designated: 49 were 18-25 years old, 68 patients were 25-35 years old, and 57 were in both age groups, 36-45 and 45-75 years. Keratoconus was diagnosed in 335 eyes with the following distribution: stage I-86, stage II-84, stage III-97, and stage IV-68 eyes. Conclusion. We examined a large number of patients preoperatively and found a higher prevalence of keratoconus than previously reported for the general population. Our particular sample does not accurately refl ect the prevalence of the disorder within the general regional population of Bosnia & Herzegovina, and Croatia. Nonetheless, our fi ndings signal a need for public health outreach and intervention for keratoconus within those regions.
We think that our community needs more screening projects for glaucoma, refraction anomalies in children and diabetic retinopathy, through which the causes of blindness would be discovered and treated on time and people would be much more educated about risks and consequences of untreated eye diseases and conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.